CMS Layoffs Announced:

The Centers for Medicare and Medicaid Services (CMS) will cut 300 jobs, raising questions about adherence to legal requirements for administering health insurance programs under the Social Security Act.

@HealthReportTV

CDC Infectious Disease Monitoring at Risk:

Are the cuts to CDC programs tracking asthma, smoking, and gun violence may weaken its legal responsibility under the Public Health Security and Bioterrorism Preparedness and Response Act to monitor health threats?

@HealthReportTV

Dear friends, could some one set up a fundraiser to cover legal fees to help Carolina Galvan in the battle to restore autonomy to Dr. Richard Urso? If you can do so please text Carolina at 281-310-0696. Pray for both of them. Allegedly these people want her to pay up to a million dollars for saving Dr. Richard Urso from what seemed to be a hush/captivity situation. Thank you all!

WHO Pandemic Agreement Adopted Without U.S. Support: The World Health Organization passed a global pandemic treaty to improve coordinated responses, but the U.S. opposed it, urging states to reject it.

Opposing the WHO Pandemic Treaty Strengthens National Sovereignty. By rejecting the WHO’s global pandemic agreement, the U.S. leadership protects its autonomy to manage public health without international overreach, ensuring policies align with American interests.

Tariffs on Medical Devices Promote Domestic Manufacturing: Proposed 50% tariffs on EU goods could encourage the growth of U.S.-based medical device production, reducing reliance on foreign supply chains and boosting local economies, despite short-term hospital cost concerns.

Opioid Settlement Funds Empower Local Solutions: The $50 billion from opioid lawsuits, distributed to states, allows communities to tailor addiction treatment programs to their needs, reflecting conservative values of local control over federal mandates.

AI Diagnostics Transform Healthcare Delivery: The FDA’s approval of an AI tool for early detection of diabetic retinopathy is a game-changer, especially for underserved communities. This private-sector innovation improves screening efficiency and reduces costs. What are your thoughts on AI involvement in healthcare?

#AIDiagnostics #HealthcareInnovation #PatientCare

@HealthReportTV

Vaping-Related Lung Injuries Prompt Calls for Balanced Regulation: A resurgence in vaping-related lung injuries has renewed focus on e-cigarette safety. Targeted regulations, paired with robust public education, can protect health while respecting individual choices.

Encouraging personal responsibility and informed decision-making is key to addressing this issue without overreach. It is also encouraged for parental involvement in decision-making for minors’ potential abuse of vaping.

#VapingHealth #PublicSafety #HealthEducation #youthvape

@HealthReportTV

Alzheimers:
Additional Clinical Trial Details:

• Trial Name and Scope: The TRAILBLAZER-ALZ 2 trial (Phase 3) was a double-blind, placebo-controlled study conducted globally, focusing on early Alzheimer’s patients with confirmed amyloid pathology via PET scans. It built on earlier trials, refining dosing and patient selection.

The trial reported amyloid-related imaging abnormalities (ARIA), including brain swelling (24% of patients) and micro-bleeding (31%), though most cases were mild and resolved over time. Five MRI scans were required to monitor side effects, ensuring patient safety.

Cost and Access: At $32,000 annually, Kisunla is pricier than Leqembi ($26,500), but its limited-duration dosing may reduce overall costs. Medicare covers it for eligible patients, though logistical hurdles like MRI availability could slow adoption.

Ongoing Research: Lilly’s TRAILBLAZER-ALZ 3 (prevention in preclinical AD) and ALZ 5 (enrolling in Korea) trials continue to explore donanemab’s potential, alongside ALZ 6, which investigates ARIA mechanisms and alternative dosing.


Are Alzheimer’s research advances, ongoing trials like TRAILBLAZER-ALZ 3 and 5 explore prevention and broader applications, promising a brighter future? What are your thoughts on balancing innovation with access to life-changing treatments?

@HealthReportTV

FDA Approves Sanofi’s Meningococcal Vaccine: The FDA granted approval for Sanofi’s new meningococcal vaccine

@HealthReportTV

Childhood Obesity Rates Continue to Rise: Description: A CDC report indicates a 5% increase in childhood obesity since 2023, with suggestions for community-based programs to promote healthy lifestyles. Effectiveness of these initiatives is still under evaluation.

@HealthReportTV

Parkinson’s Drug Trial Reports Mixed Outcomes: Description: A new dopamine agonist for Parkinson’s disease is said to have improved motor symptoms in Phase 2 trials but raised concerns about side effects. Additional research is needed to clarify its benefits.

@HealthReportTV

Rural Hospital Closures Impact Care Access: Five rural hospitals are reported to have closed in 2025, potentially creating care deserts. Mobile clinics and other solutions are being considered, with outcomes still uncertain.

@HealthReportTV

Teva’s Celiac Disease Therapy Gains FDA Fast Track Status: Teva’s investigational treatment for celiac disease, aimed at reducing gluten-induced immune responses, is reported to have received FDA Fast Track designation, which may expedite its development. Further studies will clarify its potential.

@HealthReportTV

AbbVie’s Aesthetics Division Announces Staff Reductions: AbbVie’s aesthetics unit, known for Botox, is said to be implementing layoffs due to market challenges in the cosmetic treatment sector. The extent and long-term effects remain under discussion. #HealthcareIndustry #Aesthetics

@HealthReportTV

Modular Medical to Discuss Insulin Patch Pump in Webinar: Modular Medical’s FDA-cleared MODD1 insulin patch pump, designed for user-friendly diabetes management, is set to be featured in a webinar on May 28, 2025, where its affordability and design will reportedly be highlighted. Feedback from users is anticipated. #DiabetesCare #MedicalTechnology

@HEALTHREPORTTV

Medicaid Reforms Spark Debate in Rural Areas: Proposed changes to Medicaid are said to be under discussion, with rural communities reportedly concerned about maintaining care access. Advocates and critics are weighing the potential impacts of reform. #Medicaid #RuralHealthcare

@HealthReportTV

New Insulin Delivery Technology Showcased Today: Modular Medical’s CEO is scheduled to present advancements in insulin delivery technology at a May 28 webinar, reportedly aimed at simplifying diabetes management. The technology’s reach and adoption are yet to be fully evaluated. #DiabetesManagement #HealthTech

@HealthReportTV

Wearable Device for Chronic Pain Cleared by FDA: A wearable neurostimulation device for chronic pain, such as fibromyalgia, is said to have received FDA clearance as a non-opioid treatment option. Its long-term benefits are still under review. #ChronicPain #MedicalDevices

Please share your thoughts and concerns about this!

@HealthReportTV

Low Lung Cancer Screening Rates Raise Concerns: Only 15% of eligible smokers are reportedly receiving recommended low-dose CT scans for lung cancer, prompting discussions about improving outreach and access. Solutions are still being explored. #LungCancer #Screening

@HealthReportTV

Hepatitis C Elimination Efforts Receive Funding Boost: A $500 million allocation is said to have been approved to expand hepatitis C testing and treatment in the U.S., with a goal of elimination by 2030. Progress will depend on implementation strategies. #HepatitisC #PublicHealth

@HealthReportTV